실시간 인라인 병원체 검출용 바이오센서 시장 기회, 성장 촉진요인, 업계 동향 분석 및 예측(2026-2035년)

The Global Biosensors for Real-Time In-Line Pathogen Detection Market was valued at USD 500.1 million in 2025 and is estimated to grow at a CAGR of 11.2% to reach USD 1.3 billion by 2035.

Market growth is driven by increasingly stringent regulatory requirements for preventive process monitoring, rising emphasis on food and pharmaceutical safety, and growing adoption of continuous pathogen detection technologies across industrial operations. Industries are placing greater importance on real-time monitoring solutions that enhance quality assurance while reducing operational risks and supporting regulatory compliance. The increasing incidence of foodborne illnesses worldwide has further accelerated demand for advanced biosensor technologies capable of detecting biological contaminants without interrupting production processes. As manufacturers continue to prioritize process automation, product safety, and operational efficiency, in-line biosensors are becoming an integral component of modern manufacturing infrastructure. Continuous monitoring technologies enable faster decision-making, improve process control, and minimize the risk of contamination across critical production environments. Growing investment in advanced sensing technologies, automation, and intelligent monitoring systems is expected to further strengthen market growth, positioning biosensors for in-line real-time pathogen detection as an essential solution for improving industrial safety, product quality, and regulatory compliance across multiple end-use industries.

The food and beverages processing segment accounted for 38.2% share in 2025, generating USD 191 million. Its leading position is supported by increasing adoption of continuous pathogen monitoring technologies that help manufacturers strengthen food safety programs, improve quality assurance, and comply with evolving regulatory requirements. Rising demand for automated monitoring solutions and enhanced biological hazard control continues to reinforce the importance of this application across food processing facilities.

The electrochemical biosensors segment held 38.1% share in 2025. Market leadership is supported by advantages including cost-effective operation, compatibility with compact sensing platforms, ease of integration into industrial processing systems, and reliable signal performance. Continuous improvements in sensing materials and detection capabilities are further strengthening the adoption of electrochemical biosensor technologies across industrial applications.

North America Biosensors for Real-Time In-Line Pathogen Detection Market captured 37% share in 2025. The United States continues to lead regional demand due to the strong presence of large-scale food processing facilities, pharmaceutical manufacturing operations, and widespread adoption of advanced quality monitoring technologies. Continued investment in regulatory compliance, process automation, and industrial safety solutions is expected to support sustained market growth across the region.

Major companies operating in the Global Biosensors for Real-Time In-Line Pathogen Detection Market include bioMerieux SA, Thermo Fisher Scientific, NEOGEN Corporation, QIAGEN N.V., Bio-Rad Laboratories, Merck KGaA, Microbia Environnement, Rqmicro AG, Tailin Bioengineering, FluIDect GmbH, SWIFTR Bio, Kraken Sense, and BioVind Inc. Companies participating in the biosensors for in-line real-time pathogen detection market are strengthening their competitive position through continuous investment in research and development, advanced biosensor technologies, and product innovation. Manufacturers are expanding their portfolios with highly sensitive, rapid-response detection systems that improve process efficiency and support regulatory compliance. Strategic collaborations, technology partnerships, and geographic expansion are helping companies increase market reach and strengthen customer relationships across multiple industries. Businesses are also focusing on integrating biosensors with automation platforms, digital monitoring systems, and data analytics to enhance real-time process visibility and operational efficiency.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Research approach
• 1.2 Quality Commitments
  • 1.2.1 GMI AI policy & data integrity commitment
    • 1.2.1.1 Source consistency protocol
• 1.3 Research Trail & Confidence Scoring
  • 1.3.1 Research Trail Components
  • 1.3.2 Scoring Components
• 1.4 Data Collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation for any one approach
• 1.7 Forecast model
  • 1.7.1 Quantified market impact analysis
    • 1.7.1.1 Mathematical impact of growth parameters on forecast
• 1.8 Research transparency addendum
  • 1.8.1 Source attribution framework
  • 1.8.2 Quality assurance metrics
  • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 By Technology Type
  • 2.2.3 By Bioreceptor Element
  • 2.2.4 By Pathogen Type
  • 2.2.5 By End-User Industry
• 2.3 TAM Analysis, 2026-2035
• 2.4 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Profit margin
  • 3.1.3 Value addition at each stage
  • 3.1.4 Factor affecting the value chain
  • 3.1.5 Disruptions
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
  • 3.2.2 Industry pitfalls and challenges
  • 3.2.3 Market opportunities
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East & Africa
• 3.5 Porter's analysis
• 3.6 PESTEL analysis
• 3.7 Price trends
  • 3.7.1 By region
  • 3.7.2 By Technology Type
• 3.8 Future market trends
• 3.9 Technology and Innovation landscape
  • 3.9.1 Current technological trends
  • 3.9.2 Emerging technologies
• 3.10 Patent Landscape
• 3.11 Trade statistics (HS code)
  • 3.11.1 Major importing countries
  • 3.11.2 Major exporting countries
• 3.12 Sustainability and environmental aspects
  • 3.12.1 Sustainable practices
  • 3.12.2 Waste reduction strategies
  • 3.12.3 Energy efficiency in production
  • 3.12.4 Eco friendly initiatives

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 By region
    • 4.2.1.1 North America
    • 4.2.1.2 Europe
    • 4.2.1.3 Asia Pacific
    • 4.2.1.4 LATAM
    • 4.2.1.5 MEA
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New Product Launches
  • 4.6.4 Expansion Plans

Chapter 5 Market Estimates and Forecast, By Technology Type, 2022 to 2035 (USD Million) (Tons)

• 5.1 Key trends
• 5.2 Electrochemical Biosensors
• 5.3 Optical Biosensors
• 5.4 Piezoelectric Biosensors
• 5.5 Thermal / Calorimetric
• 5.6 Others (CRISPR-LF, Microfluidic, Magnetic)

Chapter 6 Market Estimates and Forecast, By Bioreceptor Element, 2022 to 2035 (USD Million) (Tons)

• 6.1 Key trends
• 6.2 Antibody-Based (Immunosensors)
• 6.3 Nucleic Acid-Based (Aptasensors/DNA/RNA)
• 6.4 Enzyme-Based Biosensors
• 6.5 Bacteriophage-Based
• 6.6 MIP-Based
• 6.7 Others

Chapter 7 Market Estimates and Forecast, By Pathogen Type, 2022 to 2035 (USD Million) (Tons)

• 7.1 Key trends
• 7.2 Bacterial Pathogens
• 7.3 Viral Pathogens
• 7.4 Fungal & Mold Pathogens
• 7.5 Parasitic Pathogens
• 7.6 Multiplex / Multi-Pathogen Panel

Chapter 8 Market Estimates and Forecast, By End-User Industry, 2022 to 2035 (USD Million) (Tons)

• 8.1 Key trends
• 8.2 Food & Beverage Processing
• 8.3 Pharmaceutical & Biopharmaceutical
• 8.4 Water & Wastewater Treatment
• 8.5 Healthcare & Blood Supply Chain
• 8.6 Agriculture & Livestock Processing
• 8.7 Environmental Monitoring Agencies
• 8.8 Others

Chapter 9 Market Estimates and Forecast, By Region, 2022 to 2035 (USD Million) (Tons)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 bioMerieux SA
• 10.2 NEOGEN Corporation
• 10.3 Thermo Fisher Scientific Inc.
• 10.4 QIAGEN N.V.
• 10.5 Bio-Rad Laboratories Inc.
• 10.6 Tailin Bioengineering Co., Ltd.
• 10.7 Merck KGaA (MilliporeSigma)
• 10.8 Rqmicro AG
• 10.9 Microbia Environnement
• 10.10 FluIDect GmbH
• 10.11 SWIFTR Bio
• 10.12 Kraken Sense
• 10.13 BioVind Inc.